Crossmark

Direct cell reprogramming for tissue engineering and regenerative medicine

Crossref DOI link: https://doi.org/10.1186/s13036-019-0144-9

Published Online: 2019-02-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Grath, Alexander

Dai, Guohao http://orcid.org/0000-0001-7346-2685
Funding

Funding for this research was provided by:

American Heart Association (12SDG12050083)

National Institute of Health (R01HL118245, R21HD090680, R21HL102773)

National Science Foundation (1350240)
License Information

Text and Data Mining valid from 2019-02-13
More Information

Article History

Received: 6 November 2018

Accepted: 27 January 2019

First Online: 13 February 2019

Ethics approval and consent to participate

: Not applicable.

: This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License () which permits copy and redistribute the material just in non-commercial usages, provided the original work is properly cited.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.